From strategic partnerships to new community health initiatives and clinical trial announcements, see the latest ways we’re transforming the future of health and research.
The AERIFY studies from Sanofi will evaluate if the investigational treatment, itepekimab, reduces dangerous symptom flare-ups in current and former smokers with moderate-to-severe COPD. The study is offered at multiple locations in the U.S.
Read MoreA research study for heart attack and stroke prevention is available to adults 40 to 79 years of age who are at high risk for a first major atherosclerotic cardiovascular disease (ASCVD) event.
Read More
Care Access announced today the completion of a for-cause Food and Drug Administration ("FDA") Good Clinical Practices ("GCP") inspection related to Care Access's activities on the Pfizer VALOR trial. The inspection resulted in no FDA Form 483 observations...
Read More
It’s not just about diversity of staff and participants – but also diversity in how clinical research is woven into the fabric of local communities.
Read More
At Morgan CARES (Community-Aligned REsearch Solutions), we believe in the power of collaboration and partnership to drive positive change in community health. This month, we are excited to shine a spotlight on our partnership with Care Access, a global research company with a mission to accelerate the arrival of new medicines.
Read More